Warren Stone serves as Executive at NEOGENOMICS INC, where they oversee executive responsibilities. Since joining the company, Warren Stone has executed 9 insider transactions totaling $276.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2026 involved selling 22,128 shares valued at $276.7K.
Warren Stone currently holds 121,631 shares of NEOGENOMICS INC (NEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Warren Stone has been a net seller of NEO stock. They have purchased $0 and sold $276.7K worth of shares.
Warren Stone's most recent insider trade was on Jan 20, 2026, when they sold 22,128 shares at $12.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 13, 2026 | NEO | $0 | Option Exercise | 59,382 | $N/A | Discretionary |
| Dec 1, 2025 | NEO | $0 | Payment | 8,776 | $N/A | Discretionary |
| May 11, 2024 | NEO | $0 | Option Exercise | 9,612 | $N/A | Discretionary |
| May 11, 2024 | NEO | $0 | Option Exercise | 9,612 | $N/A | Discretionary |
| May 11, 2024 | NEO | $34.8K | Payment | 2,341 | $14.86 | Discretionary |
| Dec 1, 2023 | NEO | $0 | Payment | 5,431 | $N/A | Discretionary |
| Dec 1, 2022 | NEO | $0 | Award | 89,206 | $N/A | Discretionary |